Betafuse vet.
Active substance
ATC code
Species
Dogs
Indications
The veterinary medicinal product is indicated for the treatment of acute surface pyoderma, such as acute moist dermatitis (‘hot spots’) and intertrigo (skin fold dermatitis), caused by Gram-positive bacteria sensitive to fusidic acid.
Dose to be administered and administration route
Cutaneous use.
First, the hairs covering the lesions should be gently clipped. The affected area should then be thoroughly cleaned with an antiseptic wash before daily application of the gel. The amount applied should cover the affected area in a thin layer. Apply approximately 0.5 cm length of gel per 8 cm2 of lesion, twice daily, for a minimum period of 5 days. Treatment should continue for 48 hours after the lesion has resolved. The treatment period should not exceed 7 days. If there is no response within three days, or the condition deteriorates, the diagnosis should be re-evaluated.
Adverse reactions
Target species: Dogs
Undetermined frequency |
Systemic disorder (e.g. suppression of adrenal function1, thinning of the epidermis1, delayed healing1). Pigmentation disorder (e.g. depigmentation of the skin2). Hypersensitivity3. |
1 May be triggered by prolonged and intensive use of topical corticosteroid preparations or treatment of a large cutaneous surface (>10%).
2 May be caused by locally applied steroids.
3 If develops, discontinue use.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | |
EAN | 5023534028406 |